Search
Now showing items 1-10 of 12
Role of chemokines in early pregnancy loss
(Spandidos Publications, 2022)
The present study aimed to compare decidual protein levels and gene expression levels of chemokines between patients with early pregnancy loss and those with voluntary abortion. A total of 15 patients between 6 and 10 ...
Ovarian stimulation and oocyte cryopreservation in females with cancer
(Lippincott Williams & Wilkins, 2023)
Purpose of review: We reviewed the most recent developments including the safety and effectiveness data and success rates in individualized ovarian stimulation protocols for adult and postpubertal females with cancer. ...
Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency
(Springer/Plenum Publishers, 2023)
Purpose To assess the feasibility and outcomes of oocyte cryopreservation with in vitro maturation (IVM) in post-pubertal girls undergoing fertility preservation (FP) for primary ovarian insufciency (POI) risk. Methods ...
A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: Impact of BRCA pathogenic variants
(Wiley, 2023)
Background: Better tools for post-chemotherapy amenorrhea risk assessment are needed for fertility preservation decision-making. Our aim was to determine the predictors of amenorrhea risk at 12 and 18 months post-chemotherapy ...
Outcomes of random-start letrozole protocol with PGT-A in women with breast cancer undergoing fertility preservation
(Springer/Plenum Press, 2023)
PURPOSE : To compare the cycle characteristics and outcomes of random-start-controlled ovarian stimulation (RSCOS) protocols to the outcomes of standard-start-controlled ovarian stimulation (SSCOS) cycles and to report the ...
Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer
(Springer, 2021)
Purpose To determine the longitudinal impact of adjuvant chemotherapy and tamoxifen-only treatments on the reproductive potential of women with breast cancer by using a sensitive ovarian reserve marker anti-Mullerian hormone ...
Evaluation of intrafollicular syndecan 1, glypican 3, and spermidine levels in women with diminished ovarian reserve
(Springer, 2023)
We aimed to evaluate the levels of Spermidine, Syndecan 1, and Glypican 3 (GPC3) in the follicle fluid of women with diminished ovarian reserve (DOR) and to examine the relationship of these markers with the number of ...
Autologous bone marrow-derived nucleated cell (aBMNC) transplantation improves endometrial function in patients with refractory Asherman's syndrome or with thin and dysfunctional endometrium
(Springer Nature, 2023)
Purpose: The purpose was to evaluate the effect of intrauterine injection of aBMNC on the endometrial function in patients with refractory Asherman's syndrome (AS) and/or thin and dysfunctional endometrium (TE). Study ...
Association of germline BRCA pathogenic variants with diminished ovarian reserve: A meta-analysis of individual patient-level data
(American Society of Clinical Oncology, 2021)
PURPOSE: To determine whether germline BRCA (gBRCA) pathogenic variants are associated with decreased ovarian reserve. MATERIALS AND METHODS: An individual patient-level data meta-analysis was performed using five data ...
Ongoing pregnancy and healthy live births following very short ovarian stimulation of incidentally observed big antral follicles in oligoamenorrheic patients with extremely decreased ovarian reserve
(Sociedade Brasileira de Reproducao Assistida, 2021)
In the present case series our aim is to present seven patients with extremely decreased ovarian reserve and oligomenorrhea, conceived with in vitro fertilization following a very short ovarian stimulation of incidentally ...
